Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • c-Myc and β-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice
    Journal Article

    Momota, H.; Shih, A. H.; Edgar, M. A.; Holland, E. C.
    Oncogene (2008)

    Fulltext@MSK | Save
  • Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications
    Journal Article

    Miederer, M.; Scheinberg, D. A.; McDevitt, M. R.
    Advanced Drug Delivery Reviews (2008)

    Fulltext@MSK | Save
  • A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease
    Journal Article

    Maslak, P. G.; Dao, T.; Gomez, M.; Chanel, S.; Packin, J.; Korontsvit, T.; Zakhaleva, V.; Pinilla-Ibarz, J.; Berman, E.; Scheinberg, D. A.
    Leukemia (2008)

    Fulltext@MSK | Save
  • Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma
    Journal Article

    Marks, J. L.; Gong, Y.; Chitale, D.; Golas, B.; McLellan, M. D.; Kasai, Y.; Ding, L.; Mardis, E. R.; Wilson, R. K.; Solit, D.; more...
    Cancer Research (2008)

    Fulltext@MSK | Save
  • Myeloproliferative disorders
    Journal Article

    Levine, R. L.; Gilliland, D. G.
    Blood (2008)

    Fulltext@MSK | Save
  • New advances in the pathogenesis and therapy of essential thrombocythemia
    Journal Article

    Levine, R. L.; Heaney, M.
    Hematology-American Society of Hematology Education Program (2008)

    Fulltext@MSK | Save
  • JAK2V617F: You can't have too much
    Journal Article

    Levine, R. L.
    Blood (2008)

    Fulltext@MSK | Save
  • JAK2 and MPL mutations in myeloproliferative neoplasms
    Journal Article

    Koppikar, P.; Levine, R. L.
    Acta Haematologica (2008)

    Fulltext@MSK | Save
  • Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • JAK2 and MPL mutations in myeloproliferative neoplasms: Discovery and science
    Journal Article

    Kilpivaara, O.; Levine, R. L.
    Leukemia (2008)

    Fulltext@MSK | Save